US4486471A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for preparing ethylcellulose microcapsules
Assignee: Tanabe Pharma Corp
•
Filing: 1982-05-05
•
Granted: 1984-12-04
•
Expires: 2002-05-05
Abstract
Abstract Pharmaceutically active compound-containing microcapsules the coating walls of which consist essentially of ethylcellulose and a water-insoluble, acid-soluble polymer material are disclosed. A method of preparing said microcapsules is also disclosed.
Inventors
- 👤 Masayoshi Samejima
- 👤 Goichi Hirata
- 👤 Yoshiyuki Koida
- 👤 Akira Kida
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 21:28
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/5005; A61K9/5021; A61K9/5036; A61K9/5026; A61K9/5042; A61K9/5047; Y; Y10; Y10T; Y10T428/00; Y10T428/29; Y10T428/2982; Y10T428/2989
Claims Analysis
Total Claims: 24
Claim 1
Independent Claim
102 words
A method of preparing ethylcellulose microcapsules comprising: (i) dissolving ethylcellulose having an ethoxy content of 47 to 55 w/w % in cyclohexane to form a solution, (ii) dispersing particles of a pharmaceutically active compound, having a particle size of 30-1000 microns, in said solution to form a dispersion, (iii) adding a water-insoluble, acid-soluble polymer material to said dispersion in an amount of 0.1 to 20 grams per gram of said ethylcellulose, and (iv) cooling said dispersion containing said polymer material until said ethylcellulose separates therefrom to form coating walls on and around said particles of said pharmaceutically active compound thereby forming microcapsules.
Claim 2
Independent Claim
102 words
A method of preparing ethylcellulose microcapsules comprising: (i) dissolving ethylcellulose having an ethoxy content of 47 to 55 w/w % in cyclohexane to form a solution, (ii) dispersing particles of a pharmaceutically active compound, having a particle size of 30-1000 microns, in said solution to form a dispersion, (iii) adding a water-insoluble, acid-soluble polymer material to said dispersion in an amount of 0.1 to 20 grams per gram of said ethylcellulose, and (iv) cooling said dispersion containing said polymer material until said ethylcellulose separates therefrom to form coating walls on and around said particles of said pharmaceutically active compound thereby forming microcapsules.
Claim 3
Independent Claim
125 words
A method of preparing ethylcellulose microcapsules comprising: (i) dissolving ethylcellulose having a ethoxy content of 47 to 55 w/w % in cyclohexane to form a solution, (ii) dispersing particles of a pharmaceutically active compound, having a particle size of 30-1000 microns, in said solution to form a dispersion, (iii) cooling said dispersion until coating walls, having a viscosity of 0.1 to 50 P, are formed on and around said particles of said pharmaceutically active compound, (iv) adding a water-insoluble, acid-soluble polymer material to said dispersion in an amount of 0.1 to 20 grams per gram of ethylcellulose, and (v) further cooling the product of Step (iv) until the resulting embryonic microcapsules shrink and become solid by solvent loss from said coating walls thereby forming microcapsules.
Claim 4
Independent Claim
125 words
A method of preparing ethylcellulose microcapsules comprising: (i) dissolving ethylcellulose having a ethoxy content of 47 to 55 w/w % in cyclohexane to form a solution, (ii) dispersing particles of a pharmaceutically active compound, having a particle size of 30-1000 microns, in said solution to form a dispersion, (iii) cooling said dispersion until coating walls, having a viscosity of 0.1 to 50 P, are formed on and around said particles of said pharmaceutically active compound, (iv) adding a water-insoluble, acid-soluble polymer material to said dispersion in an amount of 0.1 to 20 grams per gram of ethylcellulose, and (v) further cooling the product of Step (iv) until the resulting embryonic microcapsules shrink and become solid by solvent loss from said coating walls thereby forming microcapsules.
Claim 5
Independent Claim
106 words
A method of preparing ethylcellulose microcapsules comprising: (i) dissolving ethylcellulose having an ethoxy content of 47 to 55 w/w % in cyclohexane to form a solution, (ii) dispersing particles of a pharmaceutically active compound, having a particle size of 30-1000 microns, in said solution to form a dispersion, (iii) adding a water-insoluble, acid-soluble polymer material to said dispersion in an amount of 0.1 to 20 grams per gram of said ethylcellulose, (iv) cooling said dispersion containing said polymer material until said ethylcellulose separates therefrom to form coating walls on and around said particles of said pharmaceutically active compound thereby forming microcapsules, and (v) recovering said microcapsules.
Claim 6
Independent Claim
106 words
A method of preparing ethylcellulose microcapsules comprising: (i) dissolving ethylcellulose having an ethoxy content of 47 to 55 w/w % in cyclohexane to form a solution, (ii) dispersing particles of a pharmaceutically active compound, having a particle size of 30-1000 microns, in said solution to form a dispersion, (iii) adding a water-insoluble, acid-soluble polymer material to said dispersion in an amount of 0.1 to 20 grams per gram of said ethylcellulose, (iv) cooling said dispersion containing said polymer material until said ethylcellulose separates therefrom to form coating walls on and around said particles of said pharmaceutically active compound thereby forming microcapsules, and (v) recovering said microcapsules.
Claim 7
Dependent Claim
69 words
The method according to claim 3, wherein the water-insoluble, acid-soluble polymer material is dialkylaminoalkycellulose, benzylaminoalkylcellulose, carboxyalkyl(benzylamino)cellulose, dialkylaminoacetate.cellulose.acetate, cellulose.acetate.dialkylamino.hydroxyalkyl ether, piperidyl.alkyl.hydroxyalkylcellulose, carboxyalkyl.piperidyl.starch, poly-dialkylaminoalkylstyrene, poly-vinylacetacetal.dialkylaminoacetate, 2-(p-vinylphenyl)glycine.vinyl acetate copolymer, N-vinylglycine.styrene copolymer, a copolymer of (A) dialkylaminoalkyl methacrylate and (B) one or two alkyl methacrylates, a copolymer of (A) 2-alkyl-5-vinylpyridine, (B) alkyl acrylate or acrylonitrile and (C) methacrylic acid, a copolymer of 2-vinyl-5-alkylpyridine and styrene, or a copolymer of 2-vinylpyridine and alkyl methacrylate.
Claim 8
Dependent Claim
52 words
The method according to claim 3, wherein the water-insoluble, acid-soluble polymer material is diethylaminomethylcellulose, benzylaminomethylcellulose, carboxymethyl(benzylamino)cellulose, diethylaminoacetate.cellulose.acetate, cellulose.acetate.N,N-di-n-butylamino.hydroxypropyl ether, piperidyl.ethyl.hydroxypropylcellulose, piperidyl.ethyl. hydroxyethylcellulose, carboxymethyl.piperidyl.starch, poly-diethylaminomethylstyrene, poly-vinylacetacetal.diethylaminoacetate, 2-(p-vinylphenyl)glycine.vinyl acetate copolymer, N-vinylglycine.styrene copolymer, dimethylaminoethyl methacrylate.methyl methacrylate copolymer, butyl methacrylate.2-dimethylaminoethyl methacrylate.methyl methacrylate copolymer, 2-methyl-5-vinylpyridine.methyl acrylate.methacrylic acid copolymer, 2-methyl-5-vinylpyridine.acrylonitrile.methacrylic acid copolymer, 2-vinyl-5-ethylpyridine.styrene copolymer or 2-vinylpyridine.methyl methacrylate copolymer.
Claim 9
Dependent Claim
25 words
The method according to claim 3, wherein the water-insoluble, acid-soluble polymer material is 2-methyl-5-vinylpyridine.methyl acrylate.methacrylic acid copolymer, poly-vinylacetacetal.diethylaminoacetate, dimethylaminoethyl methacrylate.methyl acrylate copolymer or cellulose.acetate.N,N-di-n-butylamino.hydroxypropyl ether.
Claim 10
Dependent Claim
42 words
The method according to claim 4, 5, 6 or 3 wherein the particles of the pharmaceutically active compound containing an organic acid are used, and said organic acid is hydroxy-lower alkane-dicarboxylic acid, hydroxy-lower alkane-tricarboxylic acid, lower alkane-dicarboxylic acid or lower alkene-dicarboxylic acid.
Claim 11
Dependent Claim
26 words
The method according to claim 7, wherein the organic acid is malic acid, tartaric acid, citric acid, malonic acid, succinic acid, maleic acid or fumaric acid.
Claim 12
Dependent Claim
33 words
The method according to claim 4, 5, 6 or 3 wherein a phase-separation-inducing agent is further added to the solution of ethylcellulose, and said phase-separation-inducing agent is polyethylene, butyl rubber, polyisobutylene or polybutadiene.
Claim 13
Dependent Claim
28 words
The method according to claim 4, 5, 6 or 3 wherein an organopolysiloxane is further added to the solution of ethylcellulose, and said organopolysiloxane is dimethylpolysiloxane or methylphenylpolysiloxane.
Claim 14
Dependent Claim
47 words
The method according to claim 4, 5, 6 or 3 wherein a surfactant is further added to the solution of ethylcellulose, and said surfactant is an ester of C 12-18 fatty acid with sorbitan, an ester of C 6-18 fatty acid with glycerin, phospholipids or calcium stearoyl-2-lactylate.
Claim 15
Independent Claim
130 words
A method of preparing ethylcellulose microcapsules comprising: (i) dissolving ethylcellulose having a ethoxy content of 47 to 55 w/w % in cyclohexane to form a solution, (ii) dispersing particles of a pharmaceutically active compound, having a particle size of 30-1000 microns, in said solution to form a dispersion, (iii) cooling said dispersion until coating walls, having a viscosity of 0.1 to 50 P, are formed on and around said particles of said pharmaceutically active compound, (iv) adding a water-insoluble, acid-soluble polymer material to said dispersion in an amount of 0.1 to 20 grams per gram of ethylcellulose, (v) further cooling the product of step (iv) until the resulting embryonic microcapsules shrink and become solid by solvent loss from said coating walls thereby forming microcapsules, and (vi) recovering the thus-formed microcapsules.
Claim 16
Independent Claim
130 words
A method of preparing ethylcellulose microcapsules comprising: (i) dissolving ethylcellulose having a ethoxy content of 47 to 55 w/w % in cyclohexane to form a solution, (ii) dispersing particles of a pharmaceutically active compound, having a particle size of 30-1000 microns, in said solution to form a dispersion, (iii) cooling said dispersion until coating walls, having a viscosity of 0.1 to 50 P, are formed on and around said particles of said pharmaceutically active compound, (iv) adding a water-insoluble, acid-soluble polymer material to said dispersion in an amount of 0.1 to 20 grams per gram of ethylcellulose, (v) further cooling the product of step (iv) until the resulting embryonic microcapsules shrink and become solid by solvent loss from said coating walls thereby forming microcapsules, and (vi) recovering the thus-formed microcapsules.
Claim 17
Dependent Claim
69 words
The method according to claim 12, wherein the water-insoluble, acid-soluble polymer material is dialkylamino-alkylcellulose, benzylaminoalkylcellulose, carboxyalkyl-(benzylamino)cellulose, dialkylaminoacetate.cellulose.acetate, cellulose.acetate.dialkylamino.hydroxyalkyl ether, piperidyl.alkyl.hydroxyalkylcellulose, carboxyalkyl.piperidyl.starch, poly-dialkylaminoalkylstyrene, poly-vinylacetacetal.dialkylaminoacetate, 2-(p-vinylphenyl)glycine.vinyl acetate copolymer, N-vinylglycine.styrene copolymer, a copolymer of (A) dialkylaminoalkyl methacrylate and (B) one or two alkyl methacrylates; a copolymer of (A) 2-alkyl-5-vinylpyridine, (B) alkyl acrylate or acrylonitrile and (C) methacrylic acid; a copolymer of 2-vinyl-5-alkylpyridine and styrene; or a copolymer of 2-vinylpyridine and alkyl methacrylate.
Claim 18
Dependent Claim
51 words
The method according to claim 12, wherein the water-insoluble, acid-soluble polymer material is diethylamino-methylcellulose, benzylaminomethylcellulose, carboxymethyl-(benzylamino)cellulose, diethylaminoacetate.cellulose.acetate, cellulose.acetate.N,N-di-n-butylamino.hydroxypropyl ether, piperidyl.ethyl.hydroxypropylcellulose, piperidyl.ethyl.hydroxyethylcellulose, carboxymethyl.piperidyl.starch, poly-diethylaminomethylstyrene, poly-vinylacetacetal.diethylaminoacetate, 2-(p-vinylphenyl)glycine.vinyl acetate copolymer, N-vinylglycine.styrene copolymer, dimethylaminoethyl methacrylate.methyl methacrylate copolymer, butyl methacrylate.2-dimethylaminoethyl methacrylate.methyl methacrylate copolymer, 2-methyl-5-vinylpyridine.methyl acrylate.methacrylic acid copolymer, 2-methyl-5-vinylpyridine.acrylonitrile.methacrylic acid copolymer, 2-vinyl-5-ethylpyridine.styrene copolymer or 2-vinylpyridine.methyl methacrylate copolymer.
Claim 19
Dependent Claim
25 words
The method according to claim 12, wherein the water-insoluble, acid-soluble polymer material is 2-methyl-5-vinylpyridine.methyl acrylate.methacrylic acid copolymer, poly-vinylacetacetal.diethylaminoacetate, dimethylaminoethyl methacrylate.methyl acrylate copolymer or cellulose.acetate.N,N-di-n-butylamino.hydroxypropyl ether.
Claim 20
Dependent Claim
42 words
The method according to claim 12, 13, 14 or 15 wherein the particles of the pharmaceutically active compound containing an organic acid are used, and said organic acid is hydroxy-lower alkane-dicarboxylic acid, hydroxy-lower alkane-tricarboxylic acid, lower alkane-dicarboxylic acid or lower alkene-dicarboxylic acid.
Claim 21
Dependent Claim
26 words
The method according to claim 16, wherein the organic acid is malic acid, tartaric acid, citric acid, malonic acid, succinic acid, maleic acid or fumaric acid.
Claim 22
Dependent Claim
33 words
The method according to claim 12, 13, 14 or 15 wherein a phase-separation-inducing agent is further added to the solution of ethylcellulose, and said phase-separation-inducing agent is polyethylene, butyl rubber, polyisobutylene or polybutadiene.
Claim 23
Dependent Claim
28 words
The method according to claim 12, 13, 14 or 15 wherein an organopolysiloxane is further added to the solution of ethlcellulose, and said organopolysiloxane is dimethylpolysiloxane or methylphenylpolysiloxane.
Claim 24
Dependent Claim
47 words
The method according to claim 12, 13, 14 or 15 wherein a surfactant is further added to the solution of ethylcellulose, and said surfactant is an ester of C 12-18 fatty acid with sorbitan, an ester of C 6-18 fatty acid with glycerin, phospholipids or calcium stearoyl-2-lactylate.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-12-04 | 1988-06-04 | 1988-12-04 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-12-04 | 1992-06-04 | 1992-12-04 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-12-04 | 1996-06-04 | 1996-12-04 | $7700.00 | Window Closed / Lapsed |